biologics.catalent.comHome - Catalent Biologics

Biologics Integrated Solutions Drug Substance Drug Product Analytical Services Gene Therapy Integrated Solutions Process Development CGMP Manufacturing Analytical Services Cell Therapy Integrated Solutions Process Industrialization CGMP Manufacturing Analytical Services Specialty Bioconjugates Bispecifics Vaccines Oncolytic Viruses Orphan Drugs Technologies Cell Line Development (GPEX®) Antibody Drug Conjugates (SMARTag®) AAV Vectors Expert Content Biologics Analytical Services Biologics Development Drug Substance Manufacturing Drug Product Manufacturing Cell Therapy Gene Therapy Subscribe About Us Overview News & Events Our Leadership Locations Careers Biologics Careers Cell & Gene Therapy Careers All Careers Catalent.com Contact Us Catalent.com Contact Us Biologics Integrated Solutions Drug Substance Drug Product Analytical Services Gene Therapy Integrated Solutions Process Development CGMP Manufacturing Analytical Services Cell Therapy Integrated Solutions Process Industrialization CGMP Manufacturing Analytical Services Specialty Bioconjugates Bispecifics Vaccines Oncolytic Viruses Orphan Drugs Technologies Cell Line Development (GPEX®) Antibody Drug Conjugates (SMARTag®) AAV Vectors Expert Content Biologics Analytical Services Biologics Development Drug Substance Manufacturing Drug Product Manufacturing Cell Therapy Gene Therapy Subscribe About Us Overview News & Events Our Leadership Locations Careers Biologics Careers Cell & Gene Therapy Careers All Careers Biologics Create better biologic treatments and speed your path to market with our range of advanced technologies and services. Learn More Catalent Partnering with Multiple Customers on COVID-Related Vaccines and Therapies Including Johnson & Johnson, AstraZeneca, Moderna and Humanigen Learn More Catalent Completes Acquisition of Manufacturing Facility from Bone Therapeutics Expanding its industry-leading cell therapy capabilities and advanced clinical and commercial supply in Belgium Learn More Developing Biologic Drugs is Science. Accelerating Advanced Treatments & Vaccines is Art. Learn More Biologics Create better biologic treatments and speed your path to market with our range of advanced technologies and services. Learn More Catalent Partnering with Multiple Customers on COVID-Related Vaccines and Therapies Including Johnson & Johnson, AstraZeneca, Moderna and Humanigen Learn More Catalent Completes Acquisition of Manufacturing Facility from Bone Therapeutics Expanding its industry-leading cell therapy capabilities and advanced clinical and commercial supply in Belgium Learn More Developing Biologic Drugs is Science. Accelerating Advanced Treatments & Vaccines is Art. Learn More How can we work together Biologics Development Gene Therapy Cell Therapy Technologies Latest News Catalent Completes Acquisition of Cell Therapy Manufacturing Facility from Bone Therapeutics CATALENT RESPONDS TO THE GLOBAL COVID-19 OUTBREAK We are taking decisive action to minimize the impact of the COVID-19 pandemic on our employees, partners, customers, and their patients. LEARN MORE Cell Therapy With our advanced technologies and expertise in both autologous and allogeneic development and manufacturing, Catalent is your full-service partner for CAR-T immunotherapies and beyond. Gene Therapy Our Gene Therapy team combines leading expertise in viral vector technology and scale-up with state-of-the-art CGMP facilities, including our FDA approved commercial facility. STRATEGIES TO ACHIEVE SUCCESSFUL COMMERCIAL APPROVAL & LAUNCH Experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the successful launch and approval of a biologic. Biologics Network Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. SEE ALL LOCATIONS Join Our Team Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. NEWS Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy Products Catalent Appoints Dr. Behzad Mahdavi as Vice President of Open Innovation, Biologics, Cell and Gene Therapy Catalent Completes Acquisition of Cell Therapy Manufacturing Facility from Bone Therapeutics Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent VIEW ALL NEWS EVENTS WCBP 2021 Navigating the Path to the Clinic and Beyond for Gene Therapies CAR-TCR Digital Summit Europe BPI Digital Week – Cell Therapy VIEW ALL EVENTS EXPERT CONTENT Advances in Analytical Technology for Biopharmaceuticals Prefilled Syringes & Parental Manufacturing Accelerating Method Transfer: Effective Automation Of Biological Assays VIEW ALL ARTICLES Expert Content Subscribe Investors Careers Contact Us Site Map Follow Us. Share Us. By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement | Cookies Settings . Copyright 2020, Catalent, Inc – All Rights Reserved Terms | Modern Slavery Statement Expert Content Subscribe Investors Careers Contact Us Site Map Follow Us. Share Us. By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement | Cookies Settings . Terms | Modern Slavery Statement Copyright 2020, Catalent, Inc All Rights Reserved SIGN UP NOW TO STAY CURRENT WITH THE LATEST NEWS AND INSIGHTS SUBSCRIBE NOW SIGN UP NOW TO STAY CURRENT WITH THE LATEST NEWS AND INSIGHTS SUBSCRIBE NOW ×...